Split GFP complementation assay:: a novel approach to quantitatively measure aggregation of tau in situ:: effects of GSK3β activation and caspase 3 cleavage

被引:47
作者
Chun, Wanjoo
Waldo, Geoffrey S.
Johnson, Gail V. W.
机构
[1] Univ Alabama, Med Sch Birmingham, Dept Psychiat, Tuscaloosa, AL 35487 USA
[2] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA
关键词
caspase-3; GSK3; beta; neurofibrillary tangles; pseudophosporylation; split GFP complementation; tau;
D O I
10.1111/j.1471-4159.2007.04941.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To quantitatively measure tau aggregation in situ, we established a cell model system using a split green fluorescence protein (GFP) complementation assay. In this assay the more aggregated the protein of interest the lower the GFP fluorescence. Tau microtubule-binding domain constructs, whose aggregation characteristics have been described previously (Khlistunova et al. 2006), were used to validate the assay. The aggregation-prone construct exhibited the lowest GFP intensity whereas the aggregation-resistant construct showed the highest GFP intensity. To examine the role of glycogen synthase kinase 3 beta (GSK3 beta) activity and caspase 3 cleavage on tau aggregation, GFP complementation of full length (T4), caspase-cleaved (T4C3), and pseudophosphorylated at S396/S404 (T4-2EC) tau was examined in the presence of an active or a kinase-dead GSK3 beta. Extensive phosphorylation of T4 by GSK3 beta resulted in increased GFP intensity. T4C3 showed neither efficient phosphorylation nor a significant GFP intensity change by GSK3 beta. The GFP intensity of T4-2EC was significantly reduced by GSK3 beta accompanying its presence in the sarkosyl-insoluble fraction, thus demonstrating that T4-2EC was partitioning into aggregates. This indicates that if the majority of tau is phosphorylated at S396/S404, in combination with increased GSK3 beta activity, tau aggregation is favored. These data demonstrate that split GFP complementation may be a valuable approach to determine the aggregation process in living cells.
引用
收藏
页码:2529 / 2539
页数:11
相关论文
共 54 条
[21]   Transgenic animal models of Alzheimer's disease and related disorders:: Histopathology, behavior and therapy [J].
Götz, J ;
Streffer, JR ;
David, D ;
Schild, A ;
Hoerndli, F ;
Pennanen, L ;
Kurosinski, P ;
Chen, F .
MOLECULAR PSYCHIATRY, 2004, 9 (07) :664-683
[22]   Memory and mental status correlates of modified Braak staging [J].
Grober, E ;
Dickson, D ;
Sliwinski, MJ ;
Buschke, H ;
Katz, M ;
Crystal, H ;
Lipton, RB .
NEUROBIOLOGY OF AGING, 1999, 20 (06) :573-579
[23]  
GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084
[24]   Pseudophosphorylation of tau protein alters its ability for self-aggregation [J].
Haase, C ;
Stieler, JT ;
Arendt, T ;
Holzer, M .
JOURNAL OF NEUROCHEMISTRY, 2004, 88 (06) :1509-1520
[25]  
Johnson GVW, 1997, J NEUROCHEM, V68, P430
[26]   The glamour and gloom of glycogen synthase kinase-3 [J].
Jope, RS ;
Johnson, GVW .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (02) :95-102
[27]   Caspase-3-mediated cleavage of PHF-1 tau during apoptosis irrespective of excitotoxicity and oxidative stress: an implication to Alzheimer's disease [J].
Kang, HJ ;
Yoon, WJ ;
Moon, GJ ;
Kim, DY ;
Sohn, S ;
Kwon, HJ ;
Gwag, BJ .
NEUROBIOLOGY OF DISEASE, 2005, 18 (03) :450-458
[28]   Inducible expression of tau repeat domain in cell models of tauopathy - Aggregation is toxic to cells but can be reversed by inhibitor drugs [J].
Khlistunova, I ;
Biernat, J ;
Wang, YP ;
Pickhardt, M ;
von Bergen, M ;
Gazova, Z ;
Mandelkow, E ;
Mandelkow, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (02) :1205-1214
[29]   MICROTUBULE-ASSOCIATED PROTEIN TAU (TAU) IS A MAJOR ANTIGENIC COMPONENT OF PAIRED HELICAL FILAMENTS IN ALZHEIMER-DISEASE [J].
KOSIK, KS ;
JOACHIM, CL ;
SELKOE, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (11) :4044-4048
[30]   Evaluating triggers and enhancers of tau fibrillization [J].
Kuret, J ;
Congdon, EE ;
Li, GB ;
Yin, HH ;
Yu, X ;
Zhong, Q .
MICROSCOPY RESEARCH AND TECHNIQUE, 2005, 67 (3-4) :141-155